Fusen Pharmaceutical Company Limited
1652.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$750.39M
Close$
Share Statistics
| Market cap | $750.39 Million |
|---|---|
| Enterprise Value | $977.02 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | 0.24 |
| Outstanding Shares | 739,301,000 |
Return
| Return on Equity | -51.31% |
|---|---|
| Return on Assets | -14.28% |
| Return on Invested Capital | -12.45% |
Valuation & Multiples
| P/E Ratio | -270.02 |
|---|---|
| PEG | 661.3 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.89 |
| Enterprise Value to EBIT | -21.49 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 0.91 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fusen Pharmaceutical Company Limited
817 employees
CEO: Zhiming Cao Fusen Pharmaceutical Company Limited operates as an investment holding enterprise, primarily engaged in the manufacturing and distribution of a diverse range of pharmaceutical products across the People's Republic of China. Its extensive...